JOHN MCCARTHY: Open Payments
NPI 1952814634 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $73 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| PFIZER INC. | 2 | $33 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: LifeVest, FARXIGA, ELIQUIS, SHINGRIX, LEQVIO, CAMZYOS, Attruby, JARDIANCE.
Industry payments across MD — which companies pay providers there.
